These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16644660)

  • 1. Counterpoint: impaired fasting glucose: The case against the new American Diabetes Association guidelines.
    Dekker JM; Balkau B
    Diabetes Care; 2006 May; 29(5):1173-5. PubMed ID: 16644660
    [No Abstract]   [Full Text] [Related]  

  • 2. Point: impaired fasting glucose: The case for the new American Diabetes Association criterion.
    Shaw JE; Zimmet PZ; Alberti KG
    Diabetes Care; 2006 May; 29(5):1170-2. PubMed ID: 16644659
    [No Abstract]   [Full Text] [Related]  

  • 3. Making things easier is not so easy. The 1997 American Diabetes Association criteria and glucose intolerance.
    Aguilar-Salinas CA; García-García E; Lerman-Garber I; Gómez-Pérez FJ; Rull JA
    Diabetes Care; 1998 Jun; 21(6):1027-8. PubMed ID: 9614628
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1).
    Phillips LS; Weintraub WS; Ziemer DC; Kolm P; Foster JK; Vaccarino V; Rhee MK; Budhwani RK; Caudle JM
    Diabetes Care; 2006 Jun; 29(6):1405-7. PubMed ID: 16732034
    [No Abstract]   [Full Text] [Related]  

  • 6. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A step backward--or is it forward?
    Genuth S; Kahn R
    Diabetes Care; 2008 Jun; 31(6):1093-6. PubMed ID: 18509143
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes or impaired glucose tolerance: does the label matter?
    Lara C; Ponce de Leon S; Foncerrada H; Vega M
    Diabetes Care; 2007 Dec; 30(12):3029-30. PubMed ID: 17728483
    [No Abstract]   [Full Text] [Related]  

  • 9. Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes.
    Oka R; Yagi K; Hifumi S; Miyamoto S; Mabuchi H; Yamagishi M; Takeda Y; Inazu A; Nohara A; Kawashiri M; Kobayashi J
    Diabet Med; 2008 Aug; 25(8):1008-10. PubMed ID: 18959620
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired fasting glucose versus impaired glucose tolerance.
    Rajendran B
    J Assoc Physicians India; 2002 Apr; 50():614; author reply 614-5. PubMed ID: 12164431
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to assess for impaired glucose tolerance before transplantation and should these results influence the choice of calcineurin inhibitors?
    Filler G; Hadjiyannakis S
    Pediatr Transplant; 2006 Feb; 10(1):1-4. PubMed ID: 16499579
    [No Abstract]   [Full Text] [Related]  

  • 13. Point-of-care testing as a tool for screening for diabetes and pre-diabetes.
    Rush E; Crook N; Simmons D
    Diabet Med; 2008 Sep; 25(9):1070-5. PubMed ID: 19183312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance and the practical implications from a clinical perspective.
    Rahme K
    Int J Clin Pract; 2008 Jul; 62(7):988-9. PubMed ID: 18564271
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impaired glucose tolerance in patients with acute myocardial infarction].
    Andersen GØ; Eritsland J; Aasheim A; Neuburger J; Knudsen EC; Mangschau A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2264-7. PubMed ID: 16967066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired fasting glucose and impaired glucose tolerance: implications for care.
    Nathan DM; Davidson MB; DeFronzo RA; Heine RJ; Henry RR; Pratley R; Zinman B;
    Diabetes Care; 2007 Mar; 30(3):753-9. PubMed ID: 17327355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.